Embion specializes in the efficient extraction of naturally-derived prebiotics for microbiome nutrition.
Embion Technologies has raised €4.5M across 2 funding rounds from 2 investors, most recently a Series A round in Dec 2021. Based in Ecublens, Switzerland; founded 2016; active in Agritech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-12-08 | Series A | €4.3M | ASAHI Group Holdings | View deal → |
| 2020-10-21 | Grant | €233k | ALCEA Foundation | View deal → |
